SURGICEL® SNoW Absorbable Hemostat
FDA premarket approval N12159/S084 · decided 2021-09-30
Approval details
- PMA number
- N12159
- Supplement
- S084
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SURGICEL® SNoW Absorbable Hemostat
- Generic name
- Agent, absorbable hemostatic, non-collagen based
- Applicant
- ETHICON, Inc.
- Date received
- 2021-08-30
- Decision date
- 2021-09-30
- Days to decision
- 31 days
- Decision code
- OK30
- Product code
- LMG
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Raritan, NJ
- Statement
- Use of a new Beamer 007-BM-206B Traverser attachment during the manufacture of Oxidized Regenerated Cellulose (ORC) for SURGICEL® SNoW Absorbable Hemostat at the Janssen Pharmaceuticals Inc. facility in Athens, Georgia, USA.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.